Macrophages display a high degree of plasticity in disease but their precise role in cancer is not well-understood. Tumour associated macrophages have been reported to facilitate tumour progression by the release of key pro-inflammatory chemotatic cytokines and growth factors. However, the role of resident liver macrophages in the progression of colorectal liver metastases and the influence of the renin-angiotensin system (RAS), which can be targeted to inhibit tumour growth, have yet to be defined. This study aims to determine if the RAS could affect macrophage activation status and if liver macrophages are altered during growth of liver metastases.